CRISPR Therapeutics To Present At The 28th Annual Piper Jaffray Healthcare Conference

BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today announced that Rodger Novak, M.D., Chief Executive Officer and Founder of CRISPR Therapeutics, will present at the 28th Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016 at the Lotte New York Palace Hotel, New York.

Event: 28th Annual Piper Jaffray Healthcare Conference

Date: Wednesday, November 30, 2016

Time: 1:30 PM ET

About CRISPR TherapeuticsCRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.
MEDIA CONTACTS:Jennifer PaganelliW2O Group for CRISPR347-658-8290 jpaganelli@w2ogroup.comINVESTOR CONTACT:Chris BrinzeyWestwicke Partners for CRISPR339-970-2843 chris.brinzey@westwicke.com

Primary Logo